Annual D&A
$9.76 B
-$516.00 M-5.02%
31 December 2023
Summary:
Bristol-Myers Squibb annual depreciation & amortization is currently $9.76 billion, with the most recent change of -$516.00 million (-5.02%) on 31 December 2023. During the last 3 years, it has fallen by -$926.00 million (-8.67%). BMY annual D&A is now -8.67% below its all-time high of $10.69 billion, reached on 31 December 2021.BMY Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$2.59 B
-$4.00 M-0.15%
30 September 2024
Summary:
Bristol-Myers Squibb quarterly depreciation & amortization is currently $2.59 billion, with the most recent change of -$4.00 million (-0.15%) on 30 September 2024. Over the past year, it has increased by +$128.00 million (+5.19%). BMY quarterly D&A is now -4.95% below its all-time high of $2.73 billion, reached on 30 September 2021.BMY Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$10.18 B
+$157.00 M+1.57%
30 September 2024
Summary:
Bristol-Myers Squibb TTM depreciation & amortization is currently $10.18 billion, with the most recent change of +$157.00 million (+1.57%) on 30 September 2024. Over the past year, it has increased by +$424.00 million (+4.34%). BMY TTM D&A is now -5.68% below its all-time high of $10.80 billion, reached on 30 September 2021.BMY TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BMY Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +5.2% | +4.3% |
| 3 y3 years | -8.7% | +0.5% | -4.7% |
| 5 y5 years | +459.0% | +109.7% | +483.3% |
BMY Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -8.7% | at low | -0.1% | +6.7% | -4.7% | +4.3% |
| 5 y | 5 years | -8.7% | +459.0% | -5.0% | +109.7% | -5.7% | +483.3% |
| alltime | all time | -8.7% | +4879.6% | -5.0% | +5084.0% | -5.7% | >+9999.0% |
Bristol-Myers Squibb Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.59 B(-0.2%) | $10.18 B(+1.6%) |
| June 2024 | - | $2.60 B(+2.5%) | $10.03 B(+1.7%) |
| Mar 2024 | - | $2.53 B(+2.8%) | $9.86 B(+1.1%) |
| Dec 2023 | $9.76 B(-5.0%) | $2.46 B(+1.2%) | $9.76 B(-0.6%) |
| Sept 2023 | - | $2.44 B(+0.1%) | $9.82 B(-1.5%) |
| June 2023 | - | $2.43 B(+0.1%) | $9.97 B(-1.5%) |
| Mar 2023 | - | $2.43 B(-3.6%) | $10.12 B(-1.5%) |
| Dec 2022 | $10.28 B(-3.8%) | $2.52 B(-2.6%) | $10.28 B(-0.6%) |
| Sept 2022 | - | $2.59 B(+0.2%) | $10.33 B(-1.3%) |
| June 2022 | - | $2.58 B(-0.0%) | $10.47 B(-1.2%) |
| Mar 2022 | - | $2.58 B(+0.2%) | $10.60 B(-0.8%) |
| Dec 2021 | $10.69 B(+2.9%) | $2.58 B(-5.4%) | $10.69 B(-1.0%) |
| Sept 2021 | - | $2.73 B(+0.6%) | $10.80 B(+0.7%) |
| June 2021 | - | $2.71 B(+1.6%) | $10.72 B(+1.5%) |
| Mar 2021 | - | $2.67 B(-0.8%) | $10.57 B(+1.8%) |
| Dec 2020 | $10.38 B(+494.5%) | $2.69 B(+1.3%) | $10.38 B(+16.3%) |
| Sept 2020 | - | $2.65 B(+3.8%) | $8.93 B(+38.6%) |
| June 2020 | - | $2.56 B(+3.3%) | $6.44 B(+58.9%) |
| Mar 2020 | - | $2.48 B(+100.4%) | $4.05 B(+132.1%) |
| Dec 2019 | $1.75 B(+174.1%) | $1.24 B(+622.8%) | $1.75 B(+156.0%) |
| Sept 2019 | - | $171.00 M(+1.2%) | $682.00 M(+0.9%) |
| June 2019 | - | $169.00 M(-0.6%) | $676.00 M(+1.8%) |
| Mar 2019 | - | $170.00 M(-1.2%) | $664.00 M(+4.2%) |
| Dec 2018 | $637.00 M(-19.3%) | $172.00 M(+4.2%) | $637.00 M(-3.8%) |
| Sept 2018 | - | $165.00 M(+5.1%) | $662.00 M(-3.4%) |
| June 2018 | - | $157.00 M(+9.8%) | $685.00 M(-7.3%) |
| Mar 2018 | - | $143.00 M(-27.4%) | $739.00 M(-6.3%) |
| Dec 2017 | $789.00 M(+106.5%) | $197.00 M(+4.8%) | $789.00 M(+10.5%) |
| Sept 2017 | - | $188.00 M(-10.9%) | $714.00 M(+13.2%) |
| June 2017 | - | $211.00 M(+9.3%) | $631.00 M(+23.7%) |
| Mar 2017 | - | $193.00 M(+58.2%) | $510.00 M(+33.5%) |
| Dec 2016 | $382.00 M(+1.6%) | $122.00 M(+16.2%) | $382.00 M(+13.7%) |
| Sept 2016 | - | $105.00 M(+16.7%) | $336.00 M(0.0%) |
| June 2016 | - | $90.00 M(+38.5%) | $336.00 M(-0.3%) |
| Mar 2016 | - | $65.00 M(-14.5%) | $337.00 M(-10.4%) |
| Dec 2015 | $376.00 M(-19.5%) | $76.00 M(-27.6%) | $376.00 M(-6.7%) |
| Sept 2015 | - | $105.00 M(+15.4%) | $403.00 M(-1.7%) |
| June 2015 | - | $91.00 M(-12.5%) | $410.00 M(-5.5%) |
| Mar 2015 | - | $104.00 M(+1.0%) | $434.00 M(-7.1%) |
| Dec 2014 | $467.00 M(-38.8%) | $103.00 M(-8.0%) | $467.00 M(-14.3%) |
| Sept 2014 | - | $112.00 M(-2.6%) | $545.00 M(-11.1%) |
| June 2014 | - | $115.00 M(-16.1%) | $613.00 M(-10.8%) |
| Mar 2014 | - | $137.00 M(-24.3%) | $687.00 M(-10.0%) |
| Dec 2013 | $763.00 M(+12.0%) | $181.00 M(+0.6%) | $763.00 M(-2.3%) |
| Sept 2013 | - | $180.00 M(-4.8%) | $781.00 M(-1.9%) |
| June 2013 | - | $189.00 M(-11.3%) | $796.00 M(+5.4%) |
| Mar 2013 | - | $213.00 M(+7.0%) | $755.00 M(+10.9%) |
| Dec 2012 | $681.00 M(+8.4%) | $199.00 M(+2.1%) | $681.00 M(+8.4%) |
| Sept 2012 | - | $195.00 M(+31.8%) | $628.00 M(+21.0%) |
| June 2012 | - | $148.00 M(+6.5%) | $519.00 M(-10.1%) |
| Mar 2012 | - | $139.00 M(-4.8%) | $577.00 M(-8.1%) |
| Dec 2011 | $628.00 M(+3.5%) | $146.00 M(+69.8%) | $628.00 M(+15.7%) |
| Sept 2011 | - | $86.00 M(-58.3%) | $543.00 M(-13.1%) |
| June 2011 | - | $206.00 M(+8.4%) | $625.00 M(+2.5%) |
| Mar 2011 | - | $190.00 M(+211.5%) | $610.00 M(+0.5%) |
| Dec 2010 | $607.00 M(-14.1%) | $61.00 M(-63.7%) | $607.00 M(-16.6%) |
| Sept 2010 | - | $168.00 M(-12.0%) | $728.00 M(-1.8%) |
| June 2010 | - | $191.00 M(+2.1%) | $741.00 M(+1.9%) |
| Mar 2010 | - | $187.00 M(+2.7%) | $727.00 M(+2.8%) |
| Dec 2009 | $707.00 M(-13.4%) | $182.00 M(+0.6%) | $707.00 M(+0.3%) |
| Sept 2009 | - | $181.00 M(+2.3%) | $705.00 M(-0.1%) |
| June 2009 | - | $177.00 M(+6.0%) | $706.00 M(-3.6%) |
| Mar 2009 | - | $167.00 M(-7.2%) | $732.00 M(-10.3%) |
| Dec 2008 | $816.00 M(-8.5%) | $180.00 M(-1.1%) | $816.00 M(-8.3%) |
| Sept 2008 | - | $182.00 M(-10.3%) | $890.00 M(-3.4%) |
| June 2008 | - | $203.00 M(-19.1%) | $921.00 M(-0.6%) |
| Mar 2008 | - | $251.00 M(-1.2%) | $927.00 M(+3.9%) |
| Dec 2007 | $892.00 M | $254.00 M(+19.2%) | $892.00 M(+2.3%) |
| Sept 2007 | - | $213.00 M(+1.9%) | $872.00 M(-1.9%) |
| June 2007 | - | $209.00 M(-3.2%) | $889.00 M(-3.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2007 | - | $216.00 M(-7.7%) | $917.00 M(-1.1%) |
| Dec 2006 | $927.00 M(-0.2%) | $234.00 M(+1.7%) | $927.00 M(-0.5%) |
| Sept 2006 | - | $230.00 M(-3.0%) | $932.00 M(+1.4%) |
| June 2006 | - | $237.00 M(+4.9%) | $919.00 M(+0.8%) |
| Mar 2006 | - | $226.00 M(-5.4%) | $912.00 M(-1.8%) |
| Dec 2005 | $929.00 M(+2.2%) | $239.00 M(+10.1%) | $929.00 M(-1.7%) |
| Sept 2005 | - | $217.00 M(-5.7%) | $945.00 M(-2.2%) |
| June 2005 | - | $230.00 M(-5.3%) | $966.00 M(+1.9%) |
| Mar 2005 | - | $243.00 M(-4.7%) | $948.00 M(+4.3%) |
| Dec 2004 | $909.00 M(+15.2%) | $255.00 M(+7.1%) | $909.00 M(+2.2%) |
| Sept 2004 | - | $238.00 M(+12.3%) | $889.00 M(+5.6%) |
| June 2004 | - | $212.00 M(+3.9%) | $842.00 M(+3.3%) |
| Mar 2004 | - | $204.00 M(-13.2%) | $815.00 M(+3.3%) |
| Dec 2003 | $789.00 M(+7.3%) | $235.00 M(+23.0%) | $789.00 M(+6.6%) |
| Sept 2003 | - | $191.00 M(+3.2%) | $740.00 M(+0.4%) |
| June 2003 | - | $185.00 M(+3.9%) | $737.00 M(+0.4%) |
| Mar 2003 | - | $178.00 M(-4.3%) | $734.00 M(-0.1%) |
| Dec 2002 | $735.00 M(+1.0%) | $186.00 M(-1.1%) | $735.00 M(-5.4%) |
| Sept 2002 | - | $188.00 M(+3.3%) | $777.00 M(+7.0%) |
| June 2002 | - | $182.00 M(+1.7%) | $726.00 M(+0.6%) |
| Mar 2002 | - | $179.00 M(-21.5%) | $722.00 M(-0.8%) |
| Dec 2001 | $728.00 M(-2.4%) | $228.00 M(+66.4%) | $728.00 M(+6.1%) |
| Sept 2001 | - | $137.00 M(-23.0%) | $686.00 M(-6.8%) |
| June 2001 | - | $178.00 M(-3.8%) | $736.00 M(-1.1%) |
| Mar 2001 | - | $185.00 M(-0.5%) | $744.00 M(-0.3%) |
| Dec 2000 | $746.00 M(+10.0%) | $186.00 M(-0.5%) | $746.00 M(-0.4%) |
| Sept 2000 | - | $187.00 M(+0.5%) | $749.00 M(+4.0%) |
| June 2000 | - | $186.00 M(-0.5%) | $720.00 M(+3.2%) |
| Mar 2000 | - | $187.00 M(-1.1%) | $698.00 M(+2.9%) |
| Dec 1999 | $678.00 M(+8.5%) | $189.00 M(+19.6%) | $678.00 M(+3.2%) |
| Sept 1999 | - | $158.00 M(-3.7%) | $657.00 M(+0.3%) |
| June 1999 | - | $164.00 M(-1.8%) | $655.00 M(+2.8%) |
| Mar 1999 | - | $167.00 M(-0.6%) | $637.00 M(+1.9%) |
| Dec 1998 | $625.00 M(+5.8%) | $168.00 M(+7.7%) | $625.00 M(-2.2%) |
| Sept 1998 | - | $156.00 M(+6.8%) | $639.00 M(+2.6%) |
| June 1998 | - | $146.00 M(-5.8%) | $623.00 M(+1.8%) |
| Mar 1998 | - | $155.00 M(-14.8%) | $612.00 M(+3.6%) |
| Dec 1997 | $591.00 M(+13.9%) | $182.00 M(+30.0%) | $591.00 M(+7.8%) |
| Sept 1997 | - | $140.00 M(+3.7%) | $548.00 M(+2.6%) |
| June 1997 | - | $135.00 M(+0.7%) | $534.00 M(+2.3%) |
| Mar 1997 | - | $134.00 M(-3.6%) | $522.00 M(+0.6%) |
| Dec 1996 | $519.00 M(+15.8%) | $139.00 M(+10.3%) | $519.00 M(-8.8%) |
| Sept 1996 | - | $126.00 M(+2.4%) | $569.00 M(+7.4%) |
| June 1996 | - | $123.00 M(-6.1%) | $530.00 M(+7.5%) |
| Mar 1996 | - | $131.00 M(-30.7%) | $493.00 M(+10.0%) |
| Dec 1995 | $448.00 M(+36.6%) | $189.00 M(+117.2%) | $448.00 M(+29.9%) |
| Sept 1995 | - | $87.00 M(+1.2%) | $345.00 M(+1.5%) |
| June 1995 | - | $86.00 M(0.0%) | $340.00 M(+1.8%) |
| Mar 1995 | - | $86.00 M(0.0%) | $334.00 M(+1.8%) |
| Dec 1994 | $328.00 M(+6.5%) | $86.00 M(+4.9%) | $328.00 M(+2.5%) |
| Sept 1994 | - | $82.00 M(+2.5%) | $320.00 M(+1.9%) |
| June 1994 | - | $80.00 M(0.0%) | $314.00 M(+0.6%) |
| Mar 1994 | - | $80.00 M(+2.6%) | $312.00 M(+1.3%) |
| Dec 1993 | $308.00 M(+4.4%) | $78.00 M(+2.6%) | $308.00 M(-0.6%) |
| Sept 1993 | - | $76.00 M(-2.6%) | $310.00 M(+0.3%) |
| June 1993 | - | $78.00 M(+2.6%) | $309.00 M(+2.3%) |
| Mar 1993 | - | $76.00 M(-5.0%) | $302.00 M(+2.4%) |
| Dec 1992 | $295.00 M(+19.9%) | $80.00 M(+6.7%) | $295.00 M(+8.9%) |
| Sept 1992 | - | $75.00 M(+5.6%) | $271.00 M(+3.8%) |
| June 1992 | - | $71.00 M(+2.9%) | $261.00 M(+8.8%) |
| Mar 1992 | - | $69.00 M(+23.2%) | $240.00 M(-2.4%) |
| Dec 1991 | $246.00 M(+0.8%) | $56.00 M(-13.8%) | $246.00 M(-2.4%) |
| Sept 1991 | - | $65.00 M(+30.0%) | $252.00 M(+2.0%) |
| June 1991 | - | $50.00 M(-33.3%) | $247.00 M(-3.9%) |
| Mar 1991 | - | $75.00 M(+21.0%) | $257.00 M(+5.3%) |
| Dec 1990 | $244.00 M(+24.5%) | $62.00 M(+3.3%) | $244.00 M(+34.1%) |
| Sept 1990 | - | $60.00 M(0.0%) | $182.00 M(+49.2%) |
| June 1990 | - | $60.00 M(-3.2%) | $122.00 M(+96.8%) |
| Mar 1990 | - | $62.00 M | $62.00 M |
| Dec 1989 | $196.00 M | - | - |
FAQ
- What is Bristol-Myers Squibb annual depreciation & amortization?
- What is the all time high annual D&A for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb quarterly D&A year-on-year change?
- What is Bristol-Myers Squibb TTM depreciation & amortization?
- What is the all time high TTM D&A for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb TTM D&A year-on-year change?
What is Bristol-Myers Squibb annual depreciation & amortization?
The current annual D&A of BMY is $9.76 B
What is the all time high annual D&A for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high annual depreciation & amortization is $10.69 B
What is Bristol-Myers Squibb quarterly depreciation & amortization?
The current quarterly D&A of BMY is $2.59 B
What is the all time high quarterly D&A for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high quarterly depreciation & amortization is $2.73 B
What is Bristol-Myers Squibb quarterly D&A year-on-year change?
Over the past year, BMY quarterly depreciation & amortization has changed by +$128.00 M (+5.19%)
What is Bristol-Myers Squibb TTM depreciation & amortization?
The current TTM D&A of BMY is $10.18 B
What is the all time high TTM D&A for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high TTM depreciation & amortization is $10.80 B
What is Bristol-Myers Squibb TTM D&A year-on-year change?
Over the past year, BMY TTM depreciation & amortization has changed by +$424.00 M (+4.34%)